James Andrea S. has filed 17 insider transactions across 1 company since June 2024.
Most recent transaction: a option exercise of 28302 shares of Insight Molecular Diagnostics Inc. ($IMDX) on March 26, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | M | Common Stock | 28302 | $0.00 | 217,358.0000 | 32,033,000 | 14.97% | 0.09% |
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | M | Restricted Stock Units | 28302 | $0.00 | 84,905.0000 | 32,033,000 | 25.00% | 0.09% |
| March 26, 2026 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | F | Common Stock | 11298 | $4.11 | 206,060.0000 | 32,033,000 | 5.20% | 0.04% |
| Oct. 31, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | M | Common Stock | 50000 | $0.00 | 201,231.0000 | 32,033,000 | 33.06% | 0.16% |
| Oct. 31, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | M | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 32,033,000 | 50.00% | 0.16% |
| Oct. 31, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | F | Common Stock | 12175 | $6.01 | 189,056.0000 | 32,033,000 | 6.05% | 0.04% |
| Oct. 31, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | D | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 32,033,000 | 9999.99% | 0.16% |
| Oct. 31, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | M | Common Stock | 50000 | $0.00 | 201,231.0000 | 32,033,000 | 33.06% | 0.16% |
| Sept. 28, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Option to Purchase Common Stock | 235000 | $0.00 | 235,000.0000 | 13,071,000 | 9999.99% | 1.80% |
| March 26, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Restricted Stock Units | 113207 | $0.00 | 113,207.0000 | 13,071,000 | 9999.99% | 0.87% |
| Feb. 7, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | P | Common Stock, no par value | 97561 | $2.05 | 151,231.0000 | 13,071,000 | 181.78% | 0.75% |
| Dec. 5, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | P | Common Stock, no par value | 20000 | $2.29 | 53,670.0000 | 13,714,000 | 59.40% | 0.15% |
| Oct. 11, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 13,714,000 | 9999.99% | 0.73% |
| Oct. 11, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Options to Purchase Common Stock | 200000 | $0.00 | 200,000.0000 | 13,714,000 | 9999.99% | 1.46% |
| Oct. 2, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | P | Common Stock, no par value | 33670 | $2.97 | 33,670.0000 | 13,714,000 | 9999.99% | 0.25% |
| June 20, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Option to Purchase Common Stock | 200000 | $0.00 | 200,000.0000 | 7,651,000 | 9999.99% | 2.61% |
| June 20, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | James Andrea S. | Chief Financial Officer | A | Restricted Stock Units | 100000 | $0.00 | 300,000.0000 | 7,651,000 | 50.00% | 1.31% |